Bicycle Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Feb 28, 2024--
Source: eagletribune.com
Page 2 - Radio Conjugates News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Radio Conjugates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Radio Conjugates Today - Breaking & Trending Today
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
Catalyst-rich 2024 with multiple clinical data readouts and updates expected for pipeline and discovery programs Phase 2/3 Duravelo-2 registrational trial for BT8009 in metastatic urothelial cancer...
Source: marketscreener.com
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
Bicycle Therapeutics (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, is today hosting a Research & Development (R&D) Day for investors and analysts in New York to provide clinical updates for BT8009, BT748
Source: pharmiweb.com
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
Nectin-4 portfolio comprised of BT8009 and BT7480 represents potential opportunity to become leader in treating Nectin-4-driven cancers, starting with metastatic urothelial cancer Updated BT8009...
Source: marketscreener.com